ResearcherThe University of SydneyNo recent work listed
Des Raymond Richardson
Matched on ORCID iD 0000-0002-5506-3274; OpenAlex author ID A5061763563. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 3 papers
Papers 9
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells. Co-author DOI 10.1016/j.biopha.2022.113736↗
- Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. Co-author DOI 10.1016/j.jbc.2022.101608↗
- Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia. Co-author DOI 10.4155/fmc-2022-0050↗
- Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma. Co-author DOI 10.1096/fj.202002279r↗
- Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells. Last author DOI 10.1016/j.bbadis.2019.165657↗
- NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane… Last author DOI 10.1016/j.bbagen.2020.129625↗
- The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Co-author DOI 10.1093/carcin/bgy178↗
- Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancreatic cancer and other tumors. Last author DOI 10.1615/critrevoncog.2013007921↗
- Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy… Last author DOI 10.1124/mol.111.073627↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sumit Sahni · 4 shared papers, 2020–2022 · strength 0.56
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells. DOI 10.1016/j.bbadis.2019.165657↗
- Paper NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancr… DOI 10.1016/j.bbagen.2020.129625↗
- Žaklina Kovačević · 5 shared papers, 2011–2022 · strength 0.49
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Bekesho Geleta · 3 shared papers, 2019–2022 · strength 0.39
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Minoti Vivek Apte · 2 shared papers, 2021–2022 · strength 0.29
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Mahendiran Dharmasivam · 1 shared paper, 2022 · strength 0.20
- Alexander Richardson · 2 shared papers, 2013–2019 · strength 0.16
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Paper Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancr… DOI 10.1615/critrevoncog.2013007921↗
- Sukriti Krishan · 1 shared paper, 2020 · strength 0.15
- Tereza Brogyányi · 1 shared paper, 2022 · strength 0.15
- Milan Jakubek · 1 shared paper, 2022 · strength 0.15
- Josef Gillson · 1 shared paper, 2020 · strength 0.13
- Zhihong Xu · 1 shared paper, 2021 · strength 0.12
- Marina Pajic · 1 shared paper, 2021 · strength 0.12
- Sharleen V. Menezes · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.